Technical Analysis for ENSC - Ensysce Biosciences, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 0.72 | 0.69% | 0.00 |
ENSC closed up 0.69 percent on Monday, February 6, 2023, on 27 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 0.00% | |
| New Uptrend | Bullish | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| NR7-2 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Fell Below 20 DMA | Bearish | 0.69% | |
| NR7 | Range Contraction | 0.69% | |
| Narrow Range Bar | Range Contraction | 0.69% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| Possible NR7 | about 4 hours ago |
| 20 DMA Resistance | about 5 hours ago |
| 10 DMA Resistance | about 5 hours ago |
| Up 3% | about 5 hours ago |
| Up 2% | about 5 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/14/2022
Ensysce Biosciences, San Diego, CA is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. Leveraging its Trypsin Activated Abuse Protection (TAAP™) and Multi-Pill Abuse Resistance (MPAR™) platforms, the Company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Ensysce’s products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing the human and economic cost. The platforms are covered by an extensive worldwide intellectual property portfolio for a wide array of prescription drug compositions.
Sector: Industrials
Industry: Conglomerates
Keywords: Health Sciences Pain Pharmacy Psychoactive Drugs Opioids Heroin Morphine Drug Culture Opioid Use Disorder Substance Dependence
Classification
Sector: Industrials
Industry: Conglomerates
Keywords: Health Sciences Pain Pharmacy Psychoactive Drugs Opioids Heroin Morphine Drug Culture Opioid Use Disorder Substance Dependence
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 34.6 |
| 52 Week Low | 0.5902 |
| Average Volume | 2,641,642 |
| 200-Day Moving Average | 7.12 |
| 50-Day Moving Average | 1.13 |
| 20-Day Moving Average | 0.73 |
| 10-Day Moving Average | 0.73 |
| Average True Range | 0.14 |
| RSI | 42.20 |
| ADX | 25.59 |
| +DI | 40.51 |
| -DI | 18.27 |
| Chandelier Exit (Long, 3 ATRs) | 1.10 |
| Chandelier Exit (Short, 3 ATRs) | 1.07 |
| Upper Bollinger Bands | 0.86 |
| Lower Bollinger Band | 0.61 |
| Percent B (%b) | 0.44 |
| BandWidth | 32.93 |
| MACD Line | -0.10 |
| MACD Signal Line | -0.14 |
| MACD Histogram | 0.0403 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.78 | ||||
| Resistance 3 (R3) | 0.78 | 0.76 | 0.77 | ||
| Resistance 2 (R2) | 0.76 | 0.74 | 0.76 | 0.77 | |
| Resistance 1 (R1) | 0.74 | 0.74 | 0.74 | 0.74 | 0.76 |
| Pivot Point | 0.72 | 0.72 | 0.72 | 0.72 | 0.72 |
| Support 1 (S1) | 0.70 | 0.70 | 0.70 | 0.70 | 0.68 |
| Support 2 (S2) | 0.68 | 0.70 | 0.68 | 0.67 | |
| Support 3 (S3) | 0.66 | 0.68 | 0.67 | ||
| Support 4 (S4) | 0.66 |
